ProfileGDS5678 / 1443078_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 7% 7% 3% 8% 29% 6% 7% 8% 6% 7% 7% 7% 7% 7% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.15587
GSM967853U87-EV human glioblastoma xenograft - Control 22.154167
GSM967854U87-EV human glioblastoma xenograft - Control 31.964623
GSM967855U87-EV human glioblastoma xenograft - Control 42.130758
GSM967856U87-EV human glioblastoma xenograft - Control 52.6122529
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.154276
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.165517
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.157298
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.110536
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.156037
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.150467
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.136657
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.153117
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.154857